E-DRUG Archives (by date)

• Thread Index

February 28, 2001
• [e-drug] Generic quality (cont)
  • From: suryawati@yogya.wasantara.net.id
• [e-drug] Unsafe injections in Pakistan (cont)
  • From: "Jatinder Singh" <jatinder7@glide.net.in>
• [e-drug] Generic prescription & rational use of drugs (cont)
  • From: hollowayk@who.ch
• [e-drug] Unsafe injections in Pakistan
  • From: hollowayk@who.ch
• [e-drug] Generic quality (cont)
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] free fluconazole for South Africa's public sector
  • From: e-drug@usa.healthnet.org
• [e-drug] HAI Europe seeks campaigns director
  • From: "Lisa Hayes" <Lisa@hai.antenna.nl>
• [e-drug] International Training Course on Drug and Therapeutic Committees, Yogyakarta 20-27 June 2001
  • From: suryawati@yogya.wasantara.net.id
• [e-drug] Generic quality (cont)
  • From: Kirsten Myhr <myhr@online.no>
February 27, 2001
• [e-drug] Drug Information Training (cont)
  • From: tmaurer@uctgsh1.uct.ac.za
• [e-drug] WTO on access to medicines (cont)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• [e-drug] Crisis in the Australian PBS (cont)
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>
• [e-drug] Generic quality (cont)
  • From: msmith@oxfam.org.uk
• [e-drug] Generic quality (cont)
  • From: msmith@oxfam.org.uk
February 26, 2001
• [e-drug] Response to Linda Horton (FDA)
  • From: James Love <love@cptech.org>
February 25, 2001
• [e-drug] After ARV price reductions what else?
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] Washington Post editorial: Patent Wrongs
  • From: Toby Kasper <tobyk@mweb.co.za>
• [e-drug] Pharmaceutical Services Distribution
  • From: "Chris Forshaw" <chris.hssp@imul.com>
• [e-drug] CPT reaction to MSF CIPLA joint statement
  • From: James Love <love@cptech.org>
• [e-drug] WTO on access to medicines
  • From: Pierre Chirac <pierchir@club-internet.fr>
• [e-drug] Drug Information Training (cont)
  • From: helpline <helpline@best.net.pk>
• [e-drug] Generic prescriptions and rational use of drugs (cont)
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] Drug Testing Laboratory (cont)
  • From: "Sake Rijpkema" <rypkemas@wxs.nl>
• [e-drug] Public Citizen letter to U.S. Health & Human Services Secretary
  • From: "Peter Lurie" <PLURIE@citizen.org>
• [e-drug] Drug Testing Laboratories (cont)
  • From: qconlab@eri.healthnet.org
February 24, 2001
• [e-drug] FDA and drug quality: response from FDA (reply)
  • From: James Love <love@cptech.org>
• [e-drug] FDA and drug quality: response from FDA
  • From: "Horton, Linda R" <LHORTON@oc.fda.gov>
• [e-drug] Dutch NGOs about South African court case
  • From: Nicole Metz <nicole.metz@wemos.nl>
• [e-drug] Generic prescription & rational use of drugs (cont)
  • From: "kspcdic" <kspcdic@blr.vsnl.net.in>
• [e-drug] Generic prescription & rational use of drugs (cont)
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>
• [e-drug] Generic prescription & rational use of drugs
  • From: Ruwan Chandana <RuwanPrsd@netscape.net>
• [e-drug] MSF/CIPLA ARV offer update
  • From: e-drug@usa.healthnet.org
February 23, 2001
• [e-drug] Mike Moore, DG of WTO, joins access debate
  • From: e-drug@usa.healthnet.org
• [e-drug] Generic quality (cont)
  • From: Jody Dalmacion <jrvd1953@yahoo.com>
• [e-drug] Drug Testing Laboratory (cont)
  • From: "Truls Eriksen" <truls_e15@hotmail.com>
• [e-drug] Generic quality (cont)
  • From: tompoe <tompoe@source.net>
• [e-drug] TB programs in Africa (cont)
  • From: "TOM MOORE" <tmoore@msh.org>
• [e-drug] Drug Testing Laboratory (cont)
  • From: ronn@dadlnet.dk
• [e-drug] Drug Information Training
  • From: Philip Anum <pw_anum@yahoo.com>
February 21, 2001
• [e-drug] UN backs use of cheap generic anti-AIDS drugs
  • From: e-drug@usa.healthnet.org
• [e-drug] Ranbaxy to foray into anti-AIDS drugs market
  • From: love@cptech.org
• [e-drug] USA to continue "flexible" trade policy on access to medicines
  • From: James Love <love@cptech.org>
• [e-drug] Brazil/WTO case: USTR Response
  • From: "Gonsalves, Gregg" <Greggg@gmhc.org>
February 20, 2001
• [e-drug] Drug Testing Laboratory (cont)
  • From: "Scott Hillstrom" <scott.hillstrom@analyticorp.co.nz>
• [e-drug] Generic quality (cont)
  • From: James Love <love@cptech.org>
• [e-drug] Crisis in the Australian PBS (cont)
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>
• [e-drug] TB programs in Africa
  • From: Oliver Hazemba <ohazemba@zamnet.zm>
• [e-drug] AIDS:First international summit for generics
  • From: "Planet Africa" <planetafrica@asso.globenet.org>
• [e-drug] Waste Management (cont)
  • From: pruessa@who.ch
• [e-drug] 2nd notice Pharmacoeconomics course: Budapest May 2001.
  • From: Dr Ruth Lopert <rlopert@mail.newcastle.edu.au>
• [e-drug] Generic quality (cont)
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] Drug Testing Laboratory
  • From: "Irfan Michael and Debbie Roy" <imderoy@super.net.pk>
• [e-drug] Generic quality (cont)
  • From: "Francisco Rossi" <francisco_rossi@hotmail.com>
• [e-drug] Reference Standards (cont)
  • From: "Sjukehusapoteket Elverum" <sjappe@apotek.no>
• [e-drug] Lamy answers EU Parliament on TRIPS and access to drugs
  • From: e-drug@usa.healthnet.org
February 19, 2001
• [e-drug] Crisis in the Australian PBS (cont)
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>
• [e-drug] Drug company payments to doctors
  • From: "Peter Mansfield" <peter.mansfield@Flinders.edu.au>
• [e-drug] The advantages of banning drug company funding of research
  • From: "Peter Mansfield" <peter.mansfield@Flinders.edu.au>
• [e-drug] A People's Charter for Health
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>
• [e-drug] Generic quality (cont)
  • From: tompoe <tompoe@source.net>
• [e-drug] Generic quality (cont)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• [e-drug] Glaxo's claims of patent protection on antiretrovirals in Ghana
  • From: Toby Kasper <tobyk@mweb.co.za>
February 18, 2001
• [e-drug] Reference Standards
  • From: "Irfan Michael and Debbie Roy" <imderoy@super.net.pk>
• [e-drug] Generic quality
  • From: msmith@oxfam.org.uk
• [e-drug] Waste Management (cont)
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] Community Pharmacy (cont)
  • From: "J.W.F. van Mil" <jwfvmil@wxs.nl>
• [e-drug] Waste Management (cont)
  • From: "J.W.F. van Mil" <jwfvmil@wxs.nl>
• [e-drug] Tribute: Doctor Charles Merieux
  • From: "Carinne Bruneton" <remed@remed.org>
February 16, 2001
• [e-drug] Wall Street Journal questionnaire on drug prices
  • From: e-drug@usa.healthnet.org
• [e-drug] Community Pharmacy
  • From: ahsan@pharmacy.isb.sdnpk.org
February 15, 2001
• [e-drug] Crisis in the Australian PBS (cont)
  • From: James Love <love@cptech.org>
• [e-drug] Waste Management
  • From: andy@healthlink.org.za
• [e-drug] Evil triumphs in a sick society
  • From: e-drug@usa.healthnet.org
February 14, 2001
• [e-drug] Crisis in the Australian PBS (cont)
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>
• [e-drug] Drugs in Sport
  • From: Leesette Turner <hamis@iafrica.com>
• [e-drug] SA opposition agrees on PI,CL
  • From: andy@healthlink.org.za
• [e-drug] Brundtland on cheaper drugs
  • From: e-drug@usa.healthnet.org
• [e-drug] GlaxoSmithKline: Drug giants aren't the problem
  • From: E-drug@usa.healthnet.org
February 13, 2001
• [e-drug] Undergraduate Pharmacist Education
  • From: Murray Bailey <murray_b@fsm.ac.fj>
• [e-drug] E-commerce in drug sales and procurement (cont)
  • From: Homira Nassery <HealthPop@worldbank.org>
• [e-drug] Recipe per patient (cont)
  • From: "Andy Gray" <agray@pixie.udw.ac.za>
• [e-drug] The prices of TB drugs (cont)
  • From: e-drug@usa.healthnet.org
• [e-drug] Cheaper MDR-TB drugs
  • From: smithi@who.ch
• [e-drug] OXFAM launches "cut the costs" campaign
  • From: e-drug@usa.healthnet.org
• [e-drug] IHT on the new drug war
  • From: e-drug@usa.healthnet.org
February 12, 2001
• [e-drug] Oxfam Launches Campaign To Fight High Prices
  • From: Dieter Neuvians MD <neuvians@mweb.co.zw>
• [e-drug] Pharmacists role in HIV/AIDS Prevention and Care
  • From: renaudtheryf@who.int
• [e-drug] The prices of TB drugs (cont)
  • From: clintox@ospedaliriuniti.bergamo.it
• [e-drug] Announcing MSH's new eBookstore
  • From: MSH Bookstore <bookstore@msh.org>
• [e-drug] Recipe per patient (cont)
  • From: Albert Figueras <afs@icf.uab.es>
• [e-drug] MSF Open Letter to Pascale Lamy on South Africa
  • From: EHOEN@paris.msf.org (Ellen T HOEN)
• [e-drug] The prices of TB drugs (cont)
  • From: Richard Laing <richardl@bu.edu>
• [e-drug] WHO's response to the CIPLA offer
  • From: EHOEN@paris.msf.org (Ellen T HOEN)
• [e-drug] The prices of TB drugs (cont)
  • From: "Natalie" <natalie@drugs.mldnet.com>
• [e-drug] WHO on low cost ARVs
  • From: e-drug@usa.healthnet.org
February 11, 2001
• [e-drug] The prices of TB drugs (cont)
  • From: Joel Lexchin <joel.lexchin@utoronto.ca>
• [e-drug] Training course (preliminary announcement)
  • From: "Perla Mordujovich" <pmordujo@atlas.med.unlp.edu.ar>
• [e-drug] Sale of fake drugs to African countries: Exports threatened
  • From: James Love <love@cptech.org>
• [e-drug] Crisis in the Australian PBS (cont)
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>
February 10, 2001
• [e-drug] NYT- Profits on Cosmetic Save a Cure for Sleeping Sickness
  • From: Holly Ladd <hladd@usa.healthnet.org>
• [e-drug] Glaxo response to Ghana problem
  • From: Anthony Cox <RX@blacktriangle.org>
• [e-drug] Triple treatment with ARVs slashed to USD175/year? (cont)
  • From: "Gonsalves, Gregg" <Greggg@gmhc.org>
• [e-drug] Triple treatment with ARVs slashed to USD175/year? (cont)
  • From: "J.W.F. van Mil" <jwfvmil@wxs.nl>
• [e-drug] The prices of TB drugs
  • From: phanouvongs@who.ch
February 09, 2001
• [e-drug] Reactions on Cipla's ARV price reduction offer
  • From: Mike Palmedo <mpalmedo@cptech.org>
• [e-drug] Triple treatment with ARVs slashed to USD175/year?
  • From: katie@CritPath.Org
February 08, 2001
• [e-drug] Global TB initiative begins push for better drugs by 2010
  • From: e-drug@usa.healthnet.org
• [e-drug] MSF press release on generic ARV prices
  • From: www.accessmed.msf.org
February 07, 2001
• [e-drug] Re: Injectable vitamins used for self-treatment? (cont)
  • From: Kirsten Myhr <myhr@online.no>
• [e-drug] ARV drugs for USD 350/year
  • From: e-drug@usa.healthnet.org
February 06, 2001
• [e-drug] NEW: Therapeutics Letter 39 now on the web!
  • From: "Ciprian Jauca" <jauca@ti.ubc.ca>
• [e-drug] Linkage of Patents and drug registration (cont)
  • From: "Dr.L.Offerhaus" <lo@euronet.nl>
• [e-drug] Recipe per patient (cont)
  • From: "Sjukehusapoteket Elverum" <sjappe@apotek.no>
• [e-drug] More on Australian PBAC
  • From: Mike Palmedo <mpalmedo@cptech.org>
• [e-drug] Time Magazine on AIDS drugs in Africa
  • From: e-drug@usa.healthnet.org
• [e-drug] Lancet editorial: correction of moderators remarks
  • From: e-drug@usa.healthnet.org
• [e-drug] Recipe per patient
  • From: Carlos Berrio <aisnic@ibw.com.ni>
• [e-drug] Linkage of Patents and drug registration (cont)
  • From: James Love <love@cptech.org>
• [e-drug] Injectable vitamins used for self-treatment? (cont)
  • From: Johny_Sulistio@notes.maxus.com
February 05, 2001
• [e-drug] Compulsory licensing: government use
  • From: e-drug@usa.healthnet.org
• [e-drug] Australian Prescriber
  • From: Susan.Reid@HEALTH.GOV.AU
• [e-drug] Australian PBAC troubles (cont)
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>
• [e-drug] AIDS: USA / BRAZIL at WTO
  • From: "Marie de Cenival" <planetafrica@asso.globenet.org>
February 04, 2001
• [e-drug] Australian PBAC troubles (cont)
  • From: Jamie Love <love@cptech.org>
• [e-drug] Reuters on WTO panel US - Brazil
  • From: EHOEN@paris.msf.org (Ellen T HOEN)
February 01, 2001
• [e-drug] Australian PBAC: more trouble (2) (cont)
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>
• [e-drug] CDC News - Special Notice on TB
  • From: Leela McCullough <leela@usa.healthnet.org>
• [e-drug] Australian PBAC: more trouble (cont)
  • From: "Ken Harvey" <k.harvey@latrobe.edu.au>